Multiple Sclerosis Info
Main Page  »  Therapies  »  Rebif  »  Research
View Article  Rash from interferon beta 1-a (Rebif or Betaseron)
We describe a 41-year-old woman with multiple sclerosis, who presented with redness of the skin; several discoloured areas; along with inflammatory small,   more »
View Article  Merck Serono Launches New Formulation Of Interferon Beta-1a
Merck Serono, a division of Merck KGaA, has announced that Rebif® New Formulation (interferon beta-1a) will be available in the UK. In a recent two-year (96 week) Phase IIIb study, 260 patients with relapsing remitting multiple sclerosis treated with the new formulation experienced a near three-fold   more »